note that most of the current buying is done "at market" by undeclared market players- that is the mark of professional accumulation- gradually so as not to spook the sheep.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025